New injectable study for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes for at least 6 months.
- Your latest HbA1c (3-month average blood sugar) is between 7.5% and 10.5%.
- Your body mass index (BMI) is between 22.5 and 40.0.
- You are not currently taking any diabetes medications other than metformin (or none at all).
- You have no history of thyroid cancer, pancreatitis, or serious stomach or gallbladder problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This trial tests an investigational drug called HDM1005 for people with type 2 diabetes whose blood sugar is still high despite taking metformin (with or without another diabetes pill called an SGLT2 inhibitor). The goal is to see if the new drug can better lower blood sugar levels.
This trial tests a new medicine, HS-20094, for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This trial tests an investigational medication (HS-20094) for people with type 2 diabetes. It aims to see if it can help control blood sugar and possibly support weight loss.
This study tests a new once-daily injection (LC-Z300-01) to see if it can lower blood sugar safely in people with type 2 diabetes. It may be a good option if your current diabetes medications aren't controlling your blood sugar as well as you'd like.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.